方盛制药 (603998.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.3x

Market Cap

CNY 4.26B

MomentumView details →

1D Return

−2.32%

YTD Return

−3.91%

RSI (14)

59.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.3x

Market Cap

CNY 4.26B

RSI (14)

59.0

MomentumView details →

1D Return

−2.32%

YTD Return

−3.91%

ProfitabilityView details →

Gross Margin

73.18%

Net Margin

17.11%

EBITDA Margin

24.71%

ROE (TTM)

17.68%

ROA (TTM)

10.03%

Asset Turnover

0.59x

GrowthView details →

Revenue YoY

+1.93%

EPS YoY

+10.84%

FCF YoY

+237.28%

Revenue CAGR 3Y

−0.85%

EPS CAGR 3Y

+1.98%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

0.90x

Quick Ratio

0.59x

Div Yield

4.17%

Div Rate

CNY 0.45

Div Growth 1Y

−26.83%

Financials snapshotView financials →

Revenue (TTM)

1.79B

Net Income (TTM)

306.52M

Op. CF (TTM)

442.89M

Latest newsMore news →

Fangsheng Pharmaceutical announced a cash dividend of 0.20 yuan per share for the first half of 2026, with total payout estimated at 88 million yuan, representing 44.43% of net profit attributable to shareholders.5d ago

Similar companies

健民集团600976.SH 太龙药业600222.SH ST中珠600568.SH Indivior Pharmaceuticals IncINDV 联环药业600513.SH 卫信康603676.SH Find similar companies →

Latest newsMore news →

Fangsheng Pharmaceutical announced a cash dividend of 0.20 yuan per share for the first half of 2026, with total payout estimated at 88 million yuan, representing 44.43% of net profit attributable to shareholders.5d ago